Low Pretreatment CD4(+):CD8(+) T Cell Ratios and CD39(+)CD73(+)CD19(+) B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma

The ectonucleotidases CD39 and CD73 are present on immune cells and play important roles in cancer progression by suppressing antitumour immunity. As such, CD39 and CD73 on peripheral blood mononuclear cells (PBMCs) are emerging as potential biomarkers to predict disease outcomes and treatment respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Ross J., Guy, Thomas V., Geraghty, Nicholas J., Splitt, Ashleigh, Watson, Debbie, Brungs, Daniel, Carolan, Martin G., Miller, Andrew A., de Leon, Jeremiah F., Aghmesheh, Morteza, Sluyter, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454544/
https://www.ncbi.nlm.nih.gov/pubmed/37628721
http://dx.doi.org/10.3390/ijms241612538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454544/
https://www.ncbi.nlm.nih.gov/pubmed/37628721
http://dx.doi.org/10.3390/ijms241612538

Ejemplares similares